Frank Mattner
Director/Miembro de la Junta en Advantage Therapeutics, Inc. .
Relaciones activas
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Jeff Madden | M | - |
Advantage Therapeutics, Inc.
 Advantage Therapeutics, Inc. Medical SpecialtiesHealth Technology ADvantage Therapeutics, Inc. is an American biotech company that focuses on developing therapies to treat neurodegenerative conditions, specifically Alzheimer's disease. The company was founded in 2021 and is based in an undisclosed location. The company's subsidiary, ADvantage Therapeutics GmbH, conducts early research and drug development. The company is developing a novel immunotherapy for early Alzheimer's disease. The company was founded by Jeffrey Bartley Madden and Agustin Fernandez Santana, with Jeffrey Bartley Madden serving as the CEO since incorporation. | - |
| David Buchsbaum | M | - |
Advantage Therapeutics, Inc.
Advantage Therapeutics, Inc. Medical SpecialtiesHealth Technology ADvantage Therapeutics, Inc. is an American biotech company that focuses on developing therapies to treat neurodegenerative conditions, specifically Alzheimer's disease. The company was founded in 2021 and is based in an undisclosed location. The company's subsidiary, ADvantage Therapeutics GmbH, conducts early research and drug development. The company is developing a novel immunotherapy for early Alzheimer's disease. The company was founded by Jeffrey Bartley Madden and Agustin Fernandez Santana, with Jeffrey Bartley Madden serving as the CEO since incorporation. | - |
| Agustin Fernandez Santana | M | - |
Advantage Therapeutics, Inc.
Advantage Therapeutics, Inc. Medical SpecialtiesHealth Technology ADvantage Therapeutics, Inc. is an American biotech company that focuses on developing therapies to treat neurodegenerative conditions, specifically Alzheimer's disease. The company was founded in 2021 and is based in an undisclosed location. The company's subsidiary, ADvantage Therapeutics GmbH, conducts early research and drug development. The company is developing a novel immunotherapy for early Alzheimer's disease. The company was founded by Jeffrey Bartley Madden and Agustin Fernandez Santana, with Jeffrey Bartley Madden serving as the CEO since incorporation. | - |
| Walter Schmidt | M | - |
Advantage Therapeutics, Inc.
Advantage Therapeutics, Inc. Medical SpecialtiesHealth Technology ADvantage Therapeutics, Inc. is an American biotech company that focuses on developing therapies to treat neurodegenerative conditions, specifically Alzheimer's disease. The company was founded in 2021 and is based in an undisclosed location. The company's subsidiary, ADvantage Therapeutics GmbH, conducts early research and drug development. The company is developing a novel immunotherapy for early Alzheimer's disease. The company was founded by Jeffrey Bartley Madden and Agustin Fernandez Santana, with Jeffrey Bartley Madden serving as the CEO since incorporation. | - |
| James O'Neill | M | - |
Advantage Therapeutics, Inc.
Advantage Therapeutics, Inc. Medical SpecialtiesHealth Technology ADvantage Therapeutics, Inc. is an American biotech company that focuses on developing therapies to treat neurodegenerative conditions, specifically Alzheimer's disease. The company was founded in 2021 and is based in an undisclosed location. The company's subsidiary, ADvantage Therapeutics GmbH, conducts early research and drug development. The company is developing a novel immunotherapy for early Alzheimer's disease. The company was founded by Jeffrey Bartley Madden and Agustin Fernandez Santana, with Jeffrey Bartley Madden serving as the CEO since incorporation. | 1 años |
Gráfico relacional
Relaciones con varias empresas
Estadísticas
| País | Relaciones | % del total |
|---|---|---|
| Estados Unidos | 5 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Frank Mattner
- Red Personal
